Home / Inspections / 1299264

FDA Inspection 1299264 — Sentry Biopharma Services, Inc.

Sentry Biopharma Services, Inc. — FEI 3007066137

The FDA completed an inspection of Sentry Biopharma Services, Inc. on December 17, 2025 in Indianapolis, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 17, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Indianapolis, IN (United States)

Facility

Other inspections at this facility

  • 1151136 (NAI Tue Jun 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 977286 (NAI Thu Jun 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 864547 (NAI Mon Feb 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 755958 (NAI Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 598198 (VAI Wed Jul 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources